Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02314546 · ClinicalTrials.gov registry record · Phase 4
Intranasal Midazolam in Children as a Pre-Operative Sedative
A Phase 4 study, sponsored by Bassett Healthcare.
- Completed
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT02314546 is a Phase 4 study that has completed, run by Bassett Healthcare. The registered enrollment target is 15 participants.
The verdict
NCT02314546, a Phase 4 study, has completed, sponsored by Bassett Healthcare.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to see if adding a numbing medicine, xylocaine, to the nasal midazolam makes giving the midazolam easier and more comfortable without affecting how the midazolam works as a sedative.
Interventions
- DRUG Midazolam
- DRUG saline placebo
- DRUG xylocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02314546
The ClinicalTrials.gov registry entry for NCT02314546 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bassett Healthcare, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Midazolam is the first listed.
NCT02314546 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02314546 about?
NCT02314546 is a clinical study titled "Intranasal Midazolam in Children as a Pre-Operative Sedative". The purpose of this study is to see if adding a numbing medicine, xylocaine, to the nasal midazolam makes giving the midazolam easier and more comfortable without affecting how the midazolam works as a sedative.
What is the current status of trial NCT02314546?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2011-12. Estimated completion is 2014-01.
What interventions are being tested in trial NCT02314546?
The interventions under investigation include: Midazolam (DRUG), saline placebo (DRUG), xylocaine (DRUG).
Who is sponsoring clinical trial NCT02314546?
This trial is sponsored by Bassett Healthcare, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.